Jarvis Securities Q&A: Expecting volumes to double (LON:JIM)
24 November 2020
Cardinal Health, Inc. (NYSE: CAH), a prominent player in the healthcare sector, is capturing the attention of investors with its notable growth potential and strategic market positioning. With a market..
Pfizer Inc. (NYSE: PFE), a prominent player in the healthcare sector, stands as a formidable force within the drug manufacturing industry. With a market capitalization of $153.81 billion, this New..
Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, continues to draw investor attention with its robust market presence and a promising growth trajectory. The company, with..
For investors navigating the ever-evolving landscape of healthcare stocks, Elevance Health, Inc. (NYSE: ELV) offers a compelling proposition with significant growth potential. With a market capitalization of $63.21 billion, Elevance..
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), a stalwart in the biotechnology industry, stands out as a compelling investment opportunity. With a robust market capitalization of $110.01 billion, Vertex continues to solidify..
Danaher Corporation (NYSE: DHR), a formidable player in the healthcare sector, is capturing investor attention with a significant potential upside of 45.94%. This diagnostics and research powerhouse operates through its..
Novartis AG (NYSE: NVS), a global healthcare titan based in Basel, Switzerland, continues to captivate investor interest with its robust market presence and compelling financial metrics. As a leading player..
Cencora, Inc. (NYSE: COR), a stalwart in the healthcare sector through its medical distribution operations, is capturing investor attention with a compelling potential upside of 30.55%. As the company continues..
Standard BioTools Inc. (NASDAQ: LAB), a key player in the healthcare sector specializing in medical devices, presents a compelling investment opportunity with its potential for a 61.80% upside, according to..
Cross Country Healthcare, Inc. (NASDAQ: CCRN) stands out as a key player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $318.75 million,..
AtaiBeckley Inc. (NASDAQ: ATAI), a clinical-stage biopharmaceutical company focused on innovative treatments for mental health disorders, is capturing significant attention from investors and analysts alike. Operating primarily in the United..
Celcuity Inc. (NASDAQ: CELC), a clinical-stage biotechnology company, is turning heads in the healthcare sector with its innovative approach to cancer treatment. Based in Minneapolis, Minnesota, Celcuity focuses on developing..
Tilray Brands, Inc. (NASDAQ: TLRY), a prominent name in the healthcare sector under the specialty and generic drug manufacturers industry, presents an intriguing opportunity for investors willing to navigate the..
SIGA Technologies Inc. (NASDAQ: SIGA), a company at the forefront of the health security market with its leading antiviral product TPOXX, presents a mixed bag for investors. The New York-based..
AngioDynamics, Inc. (NASDAQ: ANGO), a leader in the healthcare sector specializing in medical instruments and supplies, is catching the attention of investors with a noteworthy potential upside of 71.55%, according..
Sana Biotechnology, Inc. (NASDAQ: SANA) presents an intriguing opportunity for investors looking to tap into the burgeoning field of engineered cell therapies. Operating in the healthcare sector, specifically within the..
Tectonic Therapeutic, Inc. (NASDAQ: TECX) is capturing the attention of investors with its promising biotechnology innovations and an impressive potential upside of 154.39% according to analyst ratings. With its core..
Oric Pharmaceuticals, Inc. (NASDAQ: ORIC), a dynamic player in the biotech sector, is capturing the attention of investors with its promising therapeutic developments aimed at countering cancer resistance mechanisms. With..
REGENXBIO Inc. (NASDAQ: RGNX), a notable player in the biotechnology sector, is catching the eyes of investors with a staggering potential upside of 236.78%. Despite the recent challenges faced by..
